Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines
Authors: Ben S. Ou, Julie Baillet, Vittoria C. T. M. Picece, Emily C. Gale, Abigail E. Powell, Olivia M. Saouaf, Jerry Yan, Anahita Nejatfard, Hector Lopez Hernandez, Eric A. Appel